US FDA approves Bausch + Lomb, Novaliq's DED treatment Miebo
Frontiers | Deciphering the Action of Perfluorohexyloctane Eye Drops to Reduce Ocular Discomfort and Pain
Dry Eye Optometry Center of Orange County | Orange CA
PDF) Deciphering the Action of Perfluorohexyloctane Eye Drops to Reduce Ocular Discomfort and Pain
Find out more about MIEBO™ (perfluorohexyloctane ophthalmic solution).
New Dry Eye Treatment | MIEBO™ - Board Certified Eye Doctors | Burlington Bucks County Millville
Innovation in the treatment of dry eyes – EvoTears® OMEGA
Oxygen-Carrying Capacity of Perfluorohexyloctane, a Novel Eye Drop for Dry Eye Disease - ScienceDirect
Pharmaceutics | Free Full-Text | Formulation Considerations for the Management of Dry Eye Disease
Perfluorohexyloctane (F6H8) as a delivery agent for cyclosporine A in dry eye syndrome therapy – Langmuir monolayer study complemented with infrared nanospectroscopy - ScienceDirect
Bausch + Lomb and Novaliq receive FDA approval for MIEBO to treat DED
EvoTears® - URSAPHARM Arzneimittel GmbH
NovaTears® - AFT Pharmaceuticals
First of its Kind
Unique in treating dry and irritated eyes – EvoTears® OMEGA eye drops
NovaTears® | My Dry Eyes
Dry eye paradise: FDA green-lights Miebo as first and only eye drop approved for the condition
These highlights do not include all the information needed to use MIEBO safely and effectively. See full prescribing information for MIEBO. MIEBOTM (perfluorohexyloctane ophthalmic solution), for topical ophthalmic use Initial U.S. Approval:
First of its Kind
The MIEBO experience | MIEBO™ (perfluorohexyloctane ophthalmic solution)|Official HCP Site
Perfluorohexyloctane Eye Drops improve symptoms of dry eye disease linked with Meibomian gland dysfunction
FDA to Review NDA for Dry Eye Treatment | OBN
In Australia, NovaTears® Eye Drops Are Available on the Pharmaceutical Benefits Scheme (PBS) from Now On | Business Wire
Miebo, a Prescription Eye Drop for Dry Eye Disease, Now Available - MPR
